Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

類似資料

• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
  著者:: Sparreboom, Alex, 等
  出版事項: (1997)
• Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
  著者:: Mayer, U, 等
  出版事項: (1997)
• Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P‐Glycoprotein
  著者:: Kusunoki, Nobuya, 等
  出版事項: (1998)
• Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
  著者:: Asperen, J van, 等
  出版事項: (1999)
• Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid‐tumor‐bearing Mouse Models
  著者:: Watanabe, Toru, 等
  出版事項: (1996)